Name
180: Alzheimer’s Disease Agitation: Understanding Behaviors and Supporting Patient Goals and Well-Being - Supported by Supported by Axsome Therapeutics
Date & Time
Thursday, September 11, 2025, 6:30 PM - 7:30 PM
Description

Presented by Susan Scanland, MSN, GNP-BC, CDP. Light refreshments will be provided. Attendees will be admitted on a first-come basis. Explore the pathophysiology of Alzheimer’s disease agitation, its impact on patients and caregivers, and current approaches to manage unmet needs in treatment. Prepare to understand non-pharmacologic and pharmacologic treatment approaches that help providers and care-partners set attainable goals for loved ones. This presentation aims to empower providers to implement care techniques that improve quality of life for patients and their families, ultimately enhancing overall treatment outcomes. Supported by Axsome Therapeutics.

Session Type
Special